Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Ann Surg. 2015 Sep;262(3):465–475. doi: 10.1097/SLA.0000000000001383

Table 2.

(a): Multivariable Cox Model: Mortality
Parameter Hazard Ratio 95% Lower Confidence Limit for Hazard Ratio 95% Upper Confidence Limit for Hazard Ratio p-value
LDLT vs. DDLT 0.98 0.77 1.27 0.90
Female vs. male 0.74 0.58 0.94 0.01
Recipient diagnosis: malignancy other than HCC 2.16 1.13 4.11 0.02
Recipient diagnosis: PSC 0.45 0.30 0.69 <.001
On dialysis at transplant 3.59 2.05 6.28 <.001
Recipient age at transplant (per 10 years), < 55 1.20 1.00 1.44 0.05
Recipient age at transplant (per 10 years), > 55 1.65 1.27 2.15 <.001
Donor age > 50 vs. < 50 1.49 1.14 1.94 0.003
MELD at transplant (per 5 points) 1.06 0.98 1.16 0.15
(b): Multivariable Cox Model: Graft Failure
Parameter Hazard Ratio 95% Lower Confidence Limit for Hazard Ratio 95% Upper Confidence Limit for Hazard Ratio p-value
LDLT vs. DDLT 1.09 0.87 1.37 0.44
Recipient diagnosis: autoimmune hepatitis 0.44 0.24 0.82 0.009
Recipient diagnosis: HCC 1.32 1.01 1.73 0.05
Recipient diagnosis: PSC 0.66 0.47 0.93 0.02
On dialysis at transplant 2.54 1.50 4.31 <.001
Recipient age at transplant (per 10 years), < 55 1.03 0.89 1.19 0.71
Recipient age at transplant (per 10 years), > 55 1.39 1.08 1.78 0.009
Donor age > 50 vs. < 50 1.52 1.20 1.93 <.001
MELD at transplant (per 5 points) 1.09 1.00 1.17 0.04

DDLT=deceased donor liver transplant; LDLT=living donor liver transplant; HCC=hepatocellular carcinoma; HCV=hepatitis C virus; PSC=primary sclerosing cholangitis; MELD=model for end-stage liver disease;